| View |
|
DR-XY43961
|
Fluticasone propionate + Formoterol fumarate dihydrate
|
Flutiform
|
50 mcg/ 5 mcg per actuation
|
Metered Dose Inhaler (Suspension)
|
Adrenergic-Corticosteroid Combination
|
Recipharm HC Limited
|
United Kingdom
|
Initial (from Monitored Release)
|
01 December 2021
|
22 December 2024
|
| View |
|
DR-XY43962
|
Propranolol Hydrochloride
|
None
|
40 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories,Inc.
|
Philippines
|
-
|
04 November 2019
|
19 December 2024
|
| View |
|
DR-XY43963
|
Diosmin + Hesperidin
|
Vesogen
|
450/50 mg
|
Film-Coated Tablet
|
-
|
The ACME Laboratories
|
Bangladesh
|
Automatic Renewal (Reconstruction)
|
26 January 2023
|
10 December 2024
|
| View |
|
DR-XY43964
|
Fluticasone propionate + Formoterol fumarate dihydrate
|
Flutiform
|
125 mcg/ 5 mcg per actuation
|
Metered Dose Inhaler (Suspension)
|
-
|
Recipharm HC Limited
|
United Kingdom
|
-
|
01 December 2021
|
22 December 2024
|
| View |
|
DR-XY43965
|
Fluticasone propionate + Formoterol fumarate dihydrate
|
Flutiform
|
250 mcg / 10 mcg per actuation
|
Metered Dose Inhaler (Suspension)
|
-
|
Recipharm HC Limited
|
United Kingdom
|
-
|
01 December 2021
|
22 December 2024
|
| View |
|
DR-XY43967
|
Citicoline (As Sodium)
|
Neurovell
|
125mg/mL
|
Solution For Injection (IM/IV)
|
-
|
PT. Novell Pharmaceutical laboratories
|
Indonesia
|
-
|
30 September 2018
|
10 December 2024
|
| View |
|
DR-XY43972
|
Valsartan + Amlodipine (as besilate)
|
Valvex-A (80/5)
|
80mg/5mg
|
Film Coated Tablet
|
Angiotensin II Receptor Blocker/Calcium Channel Blocker
|
West-Coast Pharmaceutical Works Ltd.
|
India
|
Renewal
|
13 May 2024
|
12 January 2030
|
| View |
|
DR-XY43974
|
Guaifenesin+Chlorpheniramine Maleate+Phenylephrine Hydrochloride
|
LANGEX
|
100mg/2mg/10mg per 5mL
|
Syrup
|
-
|
La Croesus Pharma, Inc.
|
Philippines
|
-
|
13 November 2019
|
11 December 2024
|
| View |
|
DR-XY43977
|
Ceftriaxone (as Sodium)
|
Rophin
|
1g
|
Powder for Injection (IM/IV)
|
-
|
China National (Group) Corporation of Medicines, Guorui Pharmaceutical Co., Ltd.
|
China
|
-
|
19 December 2019
|
17 December 2024
|
| View |
|
DR-XY43980
|
Risedronic Acid (As Risedronate Sodium)
|
Actonate
|
32.5 mg (equivalent to 35 mg Risedronate Sodium)
|
Film-Coated Tablet
|
-
|
Aprogen Pharmaceuticals, Inc.
|
Korea
|
-
|
10 October 2019
|
15 December 2024
|
| View |
|
DR-XY43983
|
Meropenem (as trihydrate)
|
Bdmero 500
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
BDR Pharmaceuticals International Pvt. Ltd.
|
India
|
Initial (from Monitored Release)
|
31 March 2022
|
15 December 2024
|
| View |
|
DR-XY43984
|
Co-Amoxiclav
|
Moxiklav
|
1.2g
|
Powder For Injection (Iv)
|
-
|
Sichuan Pharmaceutical Inc.
|
China
|
-
|
03 January 2020
|
17 December 2024
|
| View |
|
DR-XY43987
|
Levocetirizine Hydrochloride
|
Levocer
|
10mg
|
Film Coated tablet
|
-
|
Aurochem Laboratories
|
India
|
-
|
05 December 2019
|
15 December 2024
|
| View |
|
DR-XY43988
|
Amlodipine (As Besilate) + Atorvastatin (As Calcium)
|
Amlobloc Plus
|
5mg/10mg
|
Film-Coated Tablet
|
-
|
Cadila Pharmaceuticals Limited
|
India
|
-
|
12 December 2019
|
15 December 2024
|
| View |
|
DR-XY43992
|
Risperidone
|
Noprenia
|
2mg
|
Film Coated Tablet
|
Antipsychotic
|
PT. Novell Pharmaceutical laboratories
|
Indonesia
|
Renewal
|
25 July 2024
|
16 December 2029
|
| View |
|
DR-XY43996
|
Zonisamide
|
Zonegran
|
100mg
|
Film-Coated Tablet
|
Antiepileptics (Other Antiepileptics)
|
Bora Pharmaceuticals Co., Ltd.
|
Taiwan
|
Renewal
|
24 January 2024
|
16 December 2029
|
| View |
|
DR-XY43997
|
Metformin Hydrochloride + Glipizide
|
Dibizide - M
|
500 mg/5 mg
|
Tablet
|
Oral hypoglycemic ( Biguanide and Sulfonylurea Combination )
|
Micro Labs Limited
|
India
|
Renewal
|
04 August 2024
|
16 December 2029
|
| View |
|
DR-XY43998
|
Ranolazine
|
Cartinex
|
500 mg
|
Extended Release Tablet
|
Anti-Angina
|
Micro Labs Limited
|
India
|
Initial (from Monitored Release)
|
04 April 2022
|
16 December 2024
|
| View |
|
DR-XY43999
|
Ranolazine
|
Cartinex-OD
|
1g
|
Extended Release Tablet
|
Anti-Angina
|
Micro Labs Ltd.
|
India
|
Initial
|
16 February 2022
|
16 December 2024
|
| View |
|
DR-XY44001
|
Ranitidine Hydrochloride/Tripotassium Bismuth Dicitrate/Sucralfate
|
Albis
|
84mg/100mg/300mg
|
Film Coated Tablet
|
-
|
Daewoong Pharmaceutical Co., Inc.
|
Korea
|
-
|
11 September 2019
|
17 December 2024
|